The FDA-cleared POWERWAND is the first power-injectable, extended-dwell PIV that can be used for a patient's entire length of stay of under 30 days -- for both drawing blood tests and administering medications and fluids. More than half of POWERWAND patients require only one needlestick, dramatically improving patient comfort and satisfaction. The power-injectable catheter is delivered by means of The WAND's® proprietary Accelerated Seldinger Technique, which also protects healthcare workers from dangerous accidental needlesticks

With other PIV's, hospitalized patients typically have to endure multiple needlesticks for blood draws and to receive IV medications and nutrition.


When used instead of a PICC, the POWERWAND also reduces the risk of dangerous bloodstream infections. These infections can often extend a patient's hospital stay and are costly to treat.

The INS conference was held Apr. 28-May 3 in Las Vegas.

Resources:

Study Shows POWERWAND Achieves Unprecedented Success

Access Scientific and AdvanSource Biomaterials Announce Agreement on ChronoFlex C for POWERWAND (April 26, 2011)

Access Scientific Gets FDA Clearance for POWERWAND (March 29, 2011)

About Access Scientific

Access Scientific, a privately held medical device company, is dedicated to providing a safer standard of over-wire vascular access through its proprietary WAND® technology. ASI' s team of seasoned device-company veterans is focused on improving patient and healthcare worker safety through the combination of superb design/engineering and exacting quality assurance. The WAND was developed by the same Venetec International, Inc. team that invented StatLock® catheter stabilization devices and made them the worldwide standard.

For further information on the company, go to www.The-Wand.com, email Customer Service at PCook@the-wand.com, or call 858-259-8333.

Contact: Liz Dowling, (415) 388-2794
Dowling & Dennis Public Relations
E-mail: Liz@DowlingDennis.net

Back to HCB News

More HCB News